AARTI PHARMALABS to meet investors on May 28
AARTI PHARMALABS LIMITED announced it will hold a meeting with investors and analysts on May 28, 2026, at the 360 ONE Capital Conference. The meeting will be held in physical mode to discuss ordinary business.

*this image is generated using AI for illustrative purposes only.
AARTI PHARMALABS LIMITED has scheduled a meeting with investors and analysts to discuss the ordinary course of business. The interaction is set to take place on Thursday, May 28, 2026, as part of the 360 ONE Capital Conference - Trinity 2026.
The company will engage in both one-on-one and group meetings during the event. The session will be conducted via physical mode. AARTI PHARMALABS noted that the schedule may be subject to changes depending on the analysts, institutional investors, or the company.
Event Details
The following table outlines the specifics of the upcoming conference:
| Day and Date | Name of the Event | Mode |
|---|---|---|
| Thursday, May 28, 2026 | 360 ONE Capital Conference - Trinity 2026 | Physical Mode |
The company clarified that no unpublished price sensitive information pertaining to the company will be shared during the said meeting. The intimation was made to the stock exchanges in compliance with Regulation 30 of the SEBI (LODR) Regulations 2015.
Historical Stock Returns for Aarti Pharma Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.73% | -1.68% | +0.43% | -1.07% | -18.06% | +143.10% |
What strategic growth initiatives or expansion plans might Aarti PharmaLabs highlight to institutional investors at the 360 ONE Capital Conference?
How could increased institutional investor interest following the conference impact Aarti PharmaLabs' stock liquidity and valuation multiples?
What key financial metrics or pipeline developments are analysts likely to scrutinize when evaluating Aarti PharmaLabs' near-term outlook?


































